Sold 344,631 shares of Exponent, representing an estimated $24.63 million based on the average price for the third quarter ended September 30, 2025 After the sale, the fund holds 2,361,196 shares valued at $164.06 million as of September 30, 2025 The Exponent position accounted for 2.63% of fund AUM after the sale in the third quarter of 2025
MENLO PARK, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Third Quarter of fiscal year 2025 financial results for the period ended October 3, 2025 following the close of the market on Thursday, October 30, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice Presiden...
Exponent, Inc. (NASDAQ:EXPO ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Catherine Ford Corrigan - President, CEO & Director Richard L. Schlenker - Executive VP, CFO & Corporate Secretary Conference Call Participants Karandeep Singhania - UBS Investment Bank, Research Division Tyler David Barishaw - Truist Securities, Inc., Research Division Joni Konstantelos...
MENLO PARK, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2025 ended July 4, 2025.
MENLO PARK, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on September 19, 2025, to all common stockholders of record as of September 5, 2025.
MENLO PARK, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2025 financial results for the period ended July 4, 2025 following the close of the market on Thursday, July 31, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and...
Exponent, Inc. (NASDAQ:EXPO ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Joni Konstantelos - MD, Riveron Consulting, IR Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Jasper Bibb - Truist Andrew Nicholas - William Blair Josh Chan - UBS Operator Good day and welcome to the Exponent, Inc. First Quarter 2025 Earnin...
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.